Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.13 and traded as high as $0.22. Enzon Pharmaceuticals shares last traded at $0.20, with a volume of 94,897 shares.
Enzon Pharmaceuticals Stock Up 11.0 %
The business has a fifty day moving average of $0.11 and a 200 day moving average of $0.13. The firm has a market cap of $14.84 million, a P/E ratio of 20.02 and a beta of 0.49.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Further Reading
- Five stocks we like better than Enzon Pharmaceuticals
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- Conference Calls and Individual Investors
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- How to Most Effectively Use the MarketBeat Earnings Screener
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
